Emergent Biosolutions, Inc. (EBS) Stock Rating Upgraded by BidaskClub
Separately, Zacks Investment Research lowered shares of Emergent Biosolutions from a "hold" rating to a "sell" rating in a research report on Tuesday, February 28th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company's stock.
from Biotech News
0 Comments